大禹節水(300021.SZ)5日3板 年內新增訂單已超去年全年
格隆匯8月19日丨大禹節水(300021.SZ)漲停,報6.16元,漲停封單近35萬手,暫成交1.41億元,最新總市值49億元。該股最近5個交易日已收出3個漲停板。近日,公司針對關於公司參與高標準農田建設相關問題迴應稱,公司採用EPC+0模式,為高標準農田建設提供集設計、採購、建設、運營為一體的解決方案,同時表示,公司上半年新簽訂單和在手訂單充足。大禹節水還在8月13日發佈公告披露,公司中標1.5億元上蔡縣2020年12萬畝高標準農田建設項目,至此,公司2020年內新增訂單已達23.04億元(含本次中標項目),超過去年全年訂單金額近2億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.